Spyre Therapeutics
Alex Delp is currently the Director of Operations at Spyre Therapeutics since November 2023. Before that, Alex held positions as Director of Product Operations and Senior Project Manager at Aeglea BioTherapeutics. Prior to Aeglea BioTherapeutics, Alex worked at Baltimore Research & Education Foundation, U.S. Department of Veterans Affairs, and Quotient Sciences in various project management roles. Alex earned a Bachelor's Degree in Political Science and Government from West Chester University of Pennsylvania in 2016.
This person is not in any teams
Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.